New FDA Approval of Galderma’s Sculptra® Label Means More Choice for Aesthetic Providers
The newly approved Sculptra® label has exciting implications for aesthetic injectors. Swiss pharmaceutical company Galderma has received new FDA approval for an expanded label on injectable poly-L-lactic acid (or PLLA) product Sculptra, allowing for: higher dilution new Sculptra injection techniques the option to add lidocaine immediate use after reconstitution Sculptra is already the first FDA-approved …
